Stay updated on Nivolumab & Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Ipilimumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision banner updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:40:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T16:58:55.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:58.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    An updated site revision label (Revision: v3.4.2) was added, and the previous funding notice and Revision: v3.4.1 deletion were removed; these are administrative changes unrelated to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:22:24.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A site-wide notice about government funding was added, and the site version updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:43:51.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Adds a Show glossary option and introduces updated labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a new 'Revision: v3.4.0'. The previous wording and version label ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4') were removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:39:31.000Z thumbnail image

Stay in the know with updates to Nivolumab & Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.